9/5 theflyonthewall: Bernstein identifies CLDX as biotech takeover candidate
Celldex, Seattle Genetics among biotech takeover candidates, says Bernstein
Bernstein identifies Biomarin (BMRN), Seattle Genetics (SGEN), Incyte (INCY), Celldex (CLDX), Clovis (CLVS) , Achillion (ACHN) and Ariad (ARIA) as potential takeover targets. The firm thinks that Medivation (MDVN), Achillion, and Ariad have major upcoming catalysts that could enable their stocks to break out over the next 6-12 months. The firm's favorite stocks in the sector for the rest of the year are Medivation, Celgene (CELG), and Gilead (GILD).